Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids?

YILMAZ S., KARAKAYALI O., KALE E., Akdoğan A.

XI. European Congress on Emergency Medicine, 22 - 25 Eylül 2017

  • Yayın Türü: Bildiri / Özet Bildiri
  • Kocaeli Üniversitesi Adresli: Evet